You are viewing the site in preview mode
Skip to main content
|
Variable
|
Positive-risk (No. %)
|
Univariate
|
Multivariate
|
|---|
|
No
|
Yes
|
p value
|
OR
|
95% CI
|
p value
|
|---|
|
Age (year)
| | |
0.08
| | | |
|
< 50.5
|
22 (9.5%)
|
119 (51.5%)
| | | | |
|
≥ 50.5
|
7 (3.0%)
|
83 (35.9%)
| | | | |
|
SCCA (ng/ml)
| | |
< 0.001
|
8.972
|
1.908–42.182
|
0.005
|
|
< 2.45
|
27 (12.1%)
|
81 (36.2%)
| | | | |
|
≥ 2.45
|
2 (0.9%)
|
114 (50.9%)
| | | | |
|
FIGO stage
| | |
< 0.001
|
–
|
–
|
0.065
|
|
IA2-IB2
|
21 (9.1%)
|
72 (31.2%)
| | | | |
|
IIA1-IIA2
|
8 (3.5%)
|
130 (56.3%)
| | | | |
|
SUVmax
| | |
< 0.001
|
2.943
|
1.118–7.746
|
0.029
|
|
< 7.96
|
16 (7.0%)
|
28 (12.2%)
| | | | |
|
≥ 7.96
|
12 (5.2%)
|
174 (75.7%)
| | | | |
|
MTV
| | |
< 0.001
|
–
|
–
|
0.426
|
|
< 20.88
|
24 (10.5%)
|
49 (21.4%)
| | | | |
|
≥ 20.88
|
4 (1.7%)
|
152 (66.4%)
| | | | |
|
TLG
| | |
< 0.001
|
16.201
|
1.974–132.971
|
0.01
|
|
< 137.40
|
27 (11.8%)
|
69 (30.1%)
| | | | |
|
≥ 137.40
|
1 (0.4%)
|
132 (57.6%)
| | | | |
- Abbreviation: SCCCA squamous cell carcinoma associated antigen, SUVmax maximum of standardized uptake value, MTV metabolic tumor volume, TLG total lesion glycolysis
